|
|
|
|
LEADER |
01496cas a2200421 a 4500 |
001 |
9808800 |
003 |
DNLM |
005 |
20130509062841.0 |
008 |
980806d19982001nyuqr p 0 0eng |
010 |
|
|
|a sn 98000204
|
022 |
0 |
|
|a 1097-9336
|l 1097-9336
|y 0888-319X
|
030 |
|
|
|a IVMTFJ
|
035 |
|
|
|a (DNLM)SR0093160(s)
|
035 |
|
|
|a (OCoLC)38401050
|
040 |
|
|
|a DNLM
|c DNLM
|
042 |
|
|
|a lcd
|a nsdp
|
060 |
0 |
0 |
|a W1
|b IN106DK
|
222 |
|
0 |
|a In vitro & molecular toxicology
|
245 |
0 |
0 |
|a In vitro & molecular toxicology.
|
246 |
3 |
|
|a In vitro and molecular toxicology
|
246 |
3 |
|
|a Invitro and molecular technology
|
260 |
|
|
|a Larchmont, NY :
|b Mary Ann Liebert, Inc.,
|c c1998-
|
300 |
|
|
|a v. :
|b ill.
|
310 |
|
|
|a Quarterly
|
362 |
0 |
|
|a Vol. 11, no. 1 (spring 1998)-
|
362 |
1 |
|
|a Ceased with: Vol. 14, no. 3 (fall 2001).
|
500 |
|
|
|a Title from cover.
|
510 |
1 |
|
|9 2
|a Index medicus
|x 0019-3879
|b v13n1,Spring 2000-v14n3, fall 2001
|
510 |
1 |
|
|9 2
|a MEDLINE
|b v13n1,Spring 2000-v14n3, fall 2001
|
510 |
1 |
|
|9 2
|a PubMed
|b v13n1,Spring 2000-v14n3, fall 2001
|
650 |
0 |
2 |
|a Cells
|x drug effects
|v Periodicals.
|
650 |
0 |
2 |
|a Drug Toxicity
|v Periodicals.
|
650 |
0 |
2 |
|a Toxicology
|v Periodicals.
|
780 |
0 |
0 |
|t In vitro toxicology
|x 0888-319X
|w (DLC)sn 86014525
|w (OCoLC)13535703
|
856 |
4 |
1 |
|u http://www.liebertonline.com/ivt
|
910 |
|
|
|a DP4
|
999 |
|
|
|c 91642
|d 91642
|
952 |
|
|
|0 0
|1 0
|4 0
|7 0
|9 852227
|a NA-UNAV
|b NA-UNAV
|h 1998-2001
|o NA-UNAV-852227JNL-1097-9336
|p NA-UNAV-852227JNL-91642
|t 1145045
|y JNL
|